|
Volumn 124, Issue 11, 2001, Pages 2223-2231
|
The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders
|
Author keywords
Anti neuronal antibodies; FDG PET scanning; Paraneoplastic neurological disorder
|
Indexed keywords
ANTIBODY;
FLUORODEOXYGLUCOSE F 18;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
ADULT;
AGED;
ARTICLE;
BRONCHOSCOPY;
CLINICAL ARTICLE;
FEMALE;
FOLLOW UP;
HUMAN;
IMMUNOBLOTTING;
IMMUNOCHEMISTRY;
MALE;
NEUROLOGIC DISEASE;
PARANEOPLASTIC SYNDROME;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RADIOGRAPHY;
CASE REPORT;
CLINICAL TRIAL;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
METHODOLOGY;
MIDDLE AGED;
MULTICENTER STUDY;
PARANEOPLASTIC NEUROPATHY;
RETROSPECTIVE STUDY;
SCINTISCANNING;
ADULT;
AGED;
AGED, 80 AND OVER;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
MALE;
MIDDLE AGED;
PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM;
RADIOPHARMACEUTICALS;
RETROSPECTIVE STUDIES;
TOMOGRAPHY, EMISSION-COMPUTED;
|
EID: 0034746837
PISSN: 00068950
EISSN: None
Source Type: Journal
DOI: 10.1093/brain/124.11.2223 Document Type: Article |
Times cited : (166)
|
References (15)
|